Griffiths C, Papp K, Song M, Miller M, You Y, Shen Y-K, Han C, Blauvelt A. Maintenance of Response With up to 4 Years of Continuous Guselkumab Treatment: Results From the VOYAGE 1 Phase 3 Trial. J of Skin [Internet]. 2019 Nov. 9 [cited 2024 Jul. 3];3:S17. Available from: https://jofskin.org/33014/index.php/skin/article/view/744